Related Experiment Video
Updated: Nov 16, 2025

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
The Microenvironment in Myeloproliferative Neoplasms
Gajalakshmi Ramanathan1, Angela G Fleischman2
1Division of Hematology/Oncology, Department of Medicine, University of California, 839 Health Sciences Road, Sprague Hall B100, Irvine, CA 92617, USA.
Abstract:
Chronic inflammation is a hallmark of myeloproliferative neoplasms (MPNs), with elevated levels of proinflammatory cytokines being commonly found in all 3 subtypes. Systemic inflammation is responsible for the constitutional symptoms, thrombosis risk, premature atherosclerosis, and disease evolution in MPN. Although the neoplastic clone and their differentiated progeny drive the inflammatory process, they also induce ancillary cytokine secretion from nonmalignant cells. Here, the authors describe the inflammatory milieu in MPN based on soluble factors and cellular mediators. They also discuss the prognostic value of cytokine measurements in patients with MPN and potential therapeutic strategies that target the cellular players in inflammation.
Insights
Chronic inflammation drives myeloproliferative neoplasms (MPNs) and their symptoms. Understanding the inflammatory environment and targeting its cellular players offers new therapeutic strategies for MPN patients.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Chronic inflammation is a key characteristic of myeloproliferative neoplasms (MPNs).
- Elevated proinflammatory cytokines are present in all MPN subtypes.
- Systemic inflammation contributes to MPN symptoms, thrombosis, atherosclerosis, and disease progression.
Purpose of the Study:
- To describe the inflammatory milieu in MPN.
- To explore the role of soluble factors and cellular mediators in MPN inflammation.
- To discuss the prognostic value of cytokine measurements and potential targeted therapies.
Main Methods:
- Review of the inflammatory milieu in MPN.
- Analysis of soluble factors and cellular mediators.
- Discussion of prognostic value and therapeutic strategies.
Main Results:
- Neoplastic cells and their progeny drive inflammation in MPN.
- Nonmalignant cells also contribute to cytokine secretion.
- Cytokine levels and cellular mediators define the inflammatory landscape in MPN.
Conclusions:
- The inflammatory milieu is crucial in MPN pathogenesis and progression.
- Cytokine measurements hold prognostic value for MPN patients.
- Targeting cellular inflammation mediators presents a promising therapeutic avenue for MPNs.
Related Concept Videos
The Tumor Microenvironment
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells

